IRIS UniCatt

Giaccari, Andrea
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.822
AS - Asia 5.120
EU - Europa 4.926
SA - Sud America 1.019
Continente sconosciuto - Info sul continente non disponibili 275
AF - Africa 135
OC - Oceania 21
Totale 19.318
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.604
SG - Singapore 2.259
CN - Cina 1.180
IT - Italia 925
DE - Germania 894
BR - Brasile 847
PL - Polonia 673
SE - Svezia 554
VN - Vietnam 523
FR - Francia 469
UA - Ucraina 286
GB - Regno Unito 265
FI - Finlandia 202
IE - Irlanda 201
IN - India 179
ID - Indonesia 143
RU - Federazione Russa 142
BD - Bangladesh 134
JP - Giappone 134
TR - Turchia 118
HK - Hong Kong 117
CA - Canada 106
AR - Argentina 69
NL - Olanda 67
MX - Messico 60
IQ - Iraq 51
AT - Austria 43
KR - Corea 43
ES - Italia 34
ZA - Sudafrica 32
AE - Emirati Arabi Uniti 31
EC - Ecuador 30
BE - Belgio 29
PK - Pakistan 26
SA - Arabia Saudita 25
MA - Marocco 22
IR - Iran 19
UZ - Uzbekistan 19
AU - Australia 18
CH - Svizzera 18
KE - Kenya 16
LT - Lituania 16
RO - Romania 16
PY - Paraguay 15
CO - Colombia 14
MY - Malesia 14
EG - Egitto 13
GR - Grecia 13
JM - Giamaica 13
AZ - Azerbaigian 12
DZ - Algeria 12
VE - Venezuela 12
CZ - Repubblica Ceca 11
KZ - Kazakistan 10
PE - Perù 10
PH - Filippine 10
CL - Cile 9
DK - Danimarca 9
JO - Giordania 9
AL - Albania 8
BG - Bulgaria 8
IL - Israele 8
OM - Oman 8
DO - Repubblica Dominicana 7
PT - Portogallo 7
UY - Uruguay 7
BY - Bielorussia 6
HN - Honduras 6
NG - Nigeria 6
NP - Nepal 6
SN - Senegal 6
BH - Bahrain 5
CI - Costa d'Avorio 5
CR - Costa Rica 5
KG - Kirghizistan 5
TH - Thailandia 5
TN - Tunisia 5
TT - Trinidad e Tobago 5
TW - Taiwan 5
HR - Croazia 4
MD - Moldavia 4
PA - Panama 4
SI - Slovenia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AO - Angola 3
BO - Bolivia 3
GE - Georgia 3
HU - Ungheria 3
KH - Cambogia 3
KW - Kuwait 3
LV - Lettonia 3
MZ - Mozambico 3
QA - Qatar 3
RS - Serbia 3
BJ - Benin 2
CG - Congo 2
ET - Etiopia 2
GD - Grenada 2
IS - Islanda 2
LB - Libano 2
Totale 19.009
Salva come PNG Salva come JPEG
Città #
Singapore 1.172
Ashburn 852
Chandler 708
San Jose 664
Warsaw 580
Rome 273
Beijing 228
Fairfield 217
Dublin 198
New York 192
Wilmington 188
Los Angeles 183
Houston 181
Ho Chi Minh City 178
Milan 164
San Mateo 156
Jacksonville 148
Hefei 139
Lauterbourg 137
Hanoi 128
Tokyo 123
Seattle 122
Jakarta 120
Nanjing 107
Hong Kong 95
Moscow 95
Woodbridge 92
São Paulo 87
Boston 85
Ann Arbor 84
Frankfurt am Main 83
Helsinki 83
Chicago 82
Council Bluffs 81
The Dalles 81
Kraków 79
Izmir 75
Dallas 74
St Louis 72
Princeton 68
Santa Clara 67
Munich 65
Dearborn 64
Buffalo 57
Cambridge 54
Bremen 49
Hangzhou 46
London 44
Phoenix 42
Redwood City 42
Boardman 41
Kent 39
Lappeenranta 38
Cattolica 37
Marseille 37
Seoul 37
Nuremberg 36
Turku 35
Mountain View 34
Atlanta 32
Nanchang 31
Tianjin 31
Vienna 31
Brooklyn 30
Chennai 30
Orem 30
Shanghai 30
Toronto 30
Falls Church 29
North Bergen 28
Nürnberg 28
Brussels 26
Haiphong 26
Paris 26
Rio de Janeiro 25
Amsterdam 24
Denver 24
Lancaster 24
Da Nang 23
Lawrence 23
Redmond 23
Stockholm 23
Curitiba 22
Mexico City 22
San Francisco 22
Düsseldorf 21
Johannesburg 21
Miami 21
Belo Horizonte 20
Busto Arsizio 20
Guangzhou 18
Kunming 18
Manchester 18
Montreal 18
Norwalk 18
Poplar 18
San Diego 18
Sharjah 18
Tashkent 18
Baghdad 17
Totale 10.313
Salva come PNG Salva come JPEG
Nome #
In anorexia nervosa, even a small increase in abdominal fat is responsible for the appearance of insulin resistance 407
HCC development is associated to peripheral insulin resistance in a mouse model of NASH 382
Efficacy and safety of dapagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, in diabetes mellitus. 351
Effect of Vitamin D Supplementation on Obesity-Induced Insulin Resistance: A Double-Blind, Randomized, Placebo-Controlled Trial 340
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 316
Sotagliflozin, the first dual SGLT inhibitor: Current outlook and perspectives 11 Medical and Health Sciences 1103 Clinical Sciences 299
Comment on: Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach. Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) 285
Sotagliflozin Added to Optimized Insulin Therapy Leads to Lower Rates of Clinically Relevant Hypoglycemic Events at Any HbA1c at 52 Weeks in Adults with Type 1 Diabetes 272
High-normal TSH values in obesity depends on adipose tissue rather than insulin resistance 264
Advancing Diabetes Research: a novel islet isolation method from living donors. 242
METABOLIC SYNDROME IN TRANSPLANT PATIENTS: AN UPDATING POINT OF VIEW 222
Long-term preservation of kidney function with SGLT-2 inhibitors versus comparator drugs in people with type 2 diabetes and chronic kidney disease 208
β-Cell Fate in Human Insulin Resistance and Type 2 Diabetes: A Perspective on Islet Plasticity 203
In humans increase in intrapancreatic adipose tissue predicts beta-cell dedifferentiation score before diabetes onset: A pilot study 198
Endocrine and Metabolic Insights from Pancreatic Surgery 195
β-Cell Glucose Sensitivity Is Linked to Insulin/Glucagon Bihormonal Cells in Nondiabetic Humans. 194
Pancreaticoduodenectomy model demonstrates a fundamental role of dysfunctional β cells in predicting diabetes 194
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial 193
A Rare Case of Ectopic Adrenocorticotropic Hormone Syndrome Caused by a Metastatic Neuroendocrine Tumor of the Pancreas Detected by 68Ga-DOTANOC and 18F-FDG PET/CT 190
Removal of Duodenum Elicits GLP-1 Secretion 189
Metabolic consequences of the occlusion of the main pancreatic duct with acrylic glue after pancreaticoduodenectomy 189
Effect of Dapagliflozin on Myocardial Insulin Sensitivity and Perfusion: Rationale and Design of The DAPAHEART Trial 184
The role of oxidative stress in the pathogenesis of type 2 diabetes mellitus micro- and macrovascular complications: avenues for a mechanistic-based therapeutic approach 183
Impact of the Friedewald equation vs 2 validated equations on LDL-C estimates and goal achievement in hospitalized patients with diabetes 182
The size of adrenal incidentalomas correlates with insulin resistance. Is there a cause-effect relationship? 182
Increased B-cell workload modulates proinsulin-to-insulin ratio in humans 182
D-carnosine octylester attenuates atherosclerosis and renal disease in ApoE null mice fed a Western diet through reduction of carbonyl stress and inflammation 179
Low levels of 25(OH)D and insulin-resistance: 2 unrelated features or a cause-effect in PCOS? 177
Hypovitaminosis D Is Associated with Liver Insulin Resistance in Obese Subjects 175
Beta-cell function and glucose metabolism in patients with chronic pancreatitis 174
Metabolic syndrome in transplant patients: an academic or a health burden? 170
Will vitamin D reduce insulin resistance? Still a long way to go 170
Insulin resistance alters islet morphology in nondiabetic humans 168
Single-fiber conduction velocity test allows earlier detection of abnormalities in diabetes 164
25-Hydroxyvitamin D concentration correlates with insulin-sensitivity and BMI in obesity 164
High-normal TSH values in obesity: is it insulin resistance or adipose tissue's guilt? 162
Spotlight on ertugliflozin and its potential in the treatment of type 2 diabetes: Evidence to date 162
Can vitamin D deficiency cause diabetes and cardiovascular diseases? Present evidence and future perspectives 159
First-phase insulin secretion: can its evaluation direct therapeutic approaches? 154
Noradrenergic fibers are associated with beta-cell dedifferentiation and impaired beta-cell function in humans 154
Alpha-Lipoic Acid and Glucose Metabolism: A Comprehensive Update on Biochemical and Therapeutic Features 152
Altered BAG3-insulin colocalization is associated with impaired first phase insulin secretion in humans 151
Prediabetes: how pathophysiology drives potential intervention on a subclinical disease with feared clinical consequences 150
Vitamin D deficiency: a new risk factor for type 2 diabetes? 147
IL-21 is a major negative regulator of IRF4-dependent lipolysis affecting Tregs in adipose tissue and systemic insulin sensitivity 147
Beta-cell function and glucose metabolism in patients with chronic pancreatitis 146
Continuous subcutaneous insulin infusion (CSII) in inpatient setting: unmet needs and the proposal of a CSII unit 145
Intra-islet insulin synthesis defects are associated with endoplasmic reticulum stress and loss of beta cell identity in human diabetes 144
A single bout of physical exercise improves 1-hour post-load plasma glucose in healthy young adults 142
Association of vitamin D with insulin resistance and β-cell dysfunction in subjects at risk for type 2 diabetes: Comment to Kayaniyil et al. 142
Lynch Syndrome and Thyroid Nodules: A Single Center Experience 141
Phenotype modulation in cultures of vascular smooth muscle cells from diabetic rats: association with increased nitric oxide synthase expression and superoxide anion generation 141
Blockade of receptor activator of nuclear factor-κB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus 141
Rationale and design of the DARWIN-T2D (DApagliflozin Real World evIdeNce in Type 2 Diabetes): A multicenter retrospective nationwide Italian study and crowdsourcing opportunity 141
β α-Cell glucose sensitivity is linked to insulin/glucagon bihormonal cells in nondiabetic humans 140
The interplay of extracellular vesicles in the pathogenesis of metabolic impairment and type 2 diabetes 139
The protein tyrosine phosphatase nonreceptor 22 (PTPN22) is associated with high GAD antibody titer in latent autoimmune diabetes in adults: Non Insulin Requiring Autoimmune Diabetes (NIRAD) Study 3. 137
Metabolic syndrome in subjects at high risk for type 2 diabetes: the genetic, physiopathology and evolution of type 2 diabetes (GENFIEV) study 137
A novel low-density lipoprotein receptor variant in a Ukrainian patient: a case report and overview of the disease-causing low-density lipoprotein receptor variants associated to familial hypercholesterolemia 135
Galectin-3 gene deletion results in defective adipose tissue maturation and impaired insulin sensitivity and glucose homeostasis 133
Erythrocyte membrane fluidity: A novel biomarker of residual cardiovascular risk in type 2 diabetes 132
Physical Activity and Type 2 Diabetes: In Search of a Personalized Approach to Improving β-Cell Function 131
First-phase insulin secretion: can its evaluation direct therapeutic approaches? 130
Position Statement on the management of continuous subcutaneous insulin infusion (CSII): The Italian Lazio experience 130
Metformin Benefits: Another Example for Alternative Energy Substrate Mechanism? 130
Potential cause-effect relationship between insulin autoimmune syndrome and alpha lipoic acid: Two case reports 128
Reduced incretin effect precedes diabetes development following duodenopancreatectomy in individuals without diabetes 127
Dapagliflozin improves myocardial flow reserve in patients with type 2 diabetes: the DAPAHEART Trial: a preliminary report 126
Postoperative hyperglycemia affects survival after gastrectomy for cancer: A single-center analysis using propensity score matching 126
Erythrocyte Membrane Fluidity and Omega-3 Fatty Acid Intake: Current Outlook and Perspectives for a Novel, Nutritionally Modifiable Cardiovascular Risk Factor 125
Altered GIP/GLP-1 Secretion Ratio is Associated With Impaired β Cell Function in Humans 125
Dapagliflozin treatment is associated with a reduction of epicardial adipose tissue thickness and epicardial glucose uptake in human type 2 diabetes 125
Bile modulates secretion of incretins and insulin: a study on human extrahepatic cholestasis 125
Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study 124
Glucose toxicity: the leading actor in the pathogenesis and clinical history of type 2 diabetes - mechanisms and potentials for treatment 123
The Interplay between Immune System and Microbiota in Diabetes 123
MetaLiverCat: the NAFLD/NASH multidisciplinary board at Fondazione Policlinico Gemelli IRCCS 122
An update on pancreatic regeneration mechanisms: Searching for paths to a cure for type 2 diabetes 121
A systematic comparison of protocols for recovery of high-quality rna from human islets extracted by laser capture microdissection 121
Cardiovascular events and all-cause mortality in patients with type 2 diabetes treated with dipeptidyl peptidase-4 inhibitors: An extensive meta-analysis of randomized controlled trials 121
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 118
Acute hyperglycemia and acute hyperinsulinemia decrease plasma fibrinolytic activity and increase plasminogen activator inhibitor type 1 in the rat. 117
SGLT-2 inhibitors for treatment of heart failure in patients with and without type 2 diabetes: A practical approach for routine clinical practice 116
Effect of sotagliflozin as an adjunct to insulin therapy on blood pressure and arterial stiffness in adults with type 1 diabetes: A post hoc pooled analysis of inTandem1 and inTandem2 113
Exploring Nutraceutical Approaches Linking Metabolic Syndrome and Cognitive Impairment 112
β-Adrenergic Responsive Induction of Insulin Resistance in Liver of Aging Rats 112
High titer of autoantibodies to GAD identifies a specific phenotype of adult-onset autoimmune diabetes. 110
FL-926-16, a novel bioavailable carnosinase-resistant carnosine derivative, prevents onset and stops progression of diabetic nephropathy in db/db mice 108
A single-center prospective analysis of the impact of glucose metabolism on pancreatic fistula onset after pancreaticoduodenectomy for periampullary tumors 107
Early insulin treatment in type 2 diabetes: ORIGINal sin or valuable choice as ORIGINal treatment? An open debate on the ORIGIN study results 104
Peroxiredoxin 6, a novel player in the pathogenesis of diabetes 104
Nuclear export of FoxO1 is associated with ERK signaling in β-cells lacking insulin receptors 103
Management of diabetes in older adults 103
Physicians’ misperceived cardiovascular risk and therapeutic inertia as determinants of low LDL-cholesterol targets achievement in diabetes 103
Effects of PCSK9 inhibition on glucose metabolism and β-cell function in humans: a pilot study 101
An update on pancreatic regeneration mechanisms: Searching for paths to a cure for type 2 diabetes 100
Rats that are made insulin resistant by glucosamine treatment have impaired skeletal muscle insulin receptor phosphorylation 99
Elevated 1-hour postload plasma glucose levels identify subjects with normal glucose tolerance but impaired β-cell function, insulin resistance, and worse cardiovascular risk profile: the GENFIEV study 99
Evaluation of guidelines on diabetes medication 97
Human subjects with impaired beta-cell function and glucose tolerance have higher levels of intra-islet intact GLP-1 96
Totale 16.066
Salva come PNG Salva come JPEG
Categoria #
all - tutte 77.804
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.804
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022998 0 69 50 76 78 36 65 199 40 71 129 185
2022/20231.995 230 233 161 324 115 241 58 173 255 48 83 74
2023/20241.206 56 290 47 52 63 157 113 82 26 62 95 163
2024/20252.825 78 74 201 110 155 93 105 196 387 306 600 520
2025/20267.303 909 220 509 834 1.154 407 1.249 326 554 574 324 243
2026/20271.174 360 814 0 0 0 0 0 0 0 0 0 0
Totale 19.318